Back

Up to 6-year performance and clinical outcomes of balloon expandable transcatheter aortic valve according to the implantation strategy: insight from the DIRECTAVI trial

28 August 2023 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Advances and remaining challenges in percutaneous valve intervention Intervention ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Florence Leclercq

University Hospital Arnaud de Villeneuve, Montpellier (France)

7 More presentations in this session

Presentation thumbnail
Early outcomes of the PASCAL P10 and the MitraClip XT transcatheter mitral leaflet approximation devices - A propensity score matched multicentre comparison
Doctor P. von Stein (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Predictors of permanent pacemaker implantation after transcatheter aortic valve implantation - Results from the SOLVE-TAVI trial
Doctor H. Feistritzer (Leipzig, DE)
Abstract Slides Video
Presentation thumbnail
Clinical and neurocognitive outcomes in patients with supra-arch vascular disease following transcatheter aortic valve replacement
Doctor T. Ko (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Influence of device generations on alternations of mitral annulus after transcatheter edge-to-edge repair: a real-time three-dimensional transesophageal echocardiography study
Ms M. Ohmori (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Prevalence and predictors of pacemaker implantation in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: TAVI-NOR study
Mr D. Wasim (Bergen, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Advances and remaining challenges in percutaneous valve intervention

The Event

Event poster

ESC Congress 2023

28 August 2023 11:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources